30157956|t|Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
30157956|a|Amyotrophic lateral sclerosis (ALS) is a devastating and fatal motor neuron disease. Diagnosis typically occurs in the fifth decade of life and the disease progresses rapidly leading to death within ~ 2-5 years of symptomatic onset. There is no cure, and the few available treatments offer only a modest extension in patient survival. A protein central to ALS is the nuclear RNA/DNA-binding protein, TDP-43. In > 95% of ALS patients, TDP-43 is cleared from the nucleus and forms phosphorylated protein aggregates in the cytoplasm of affected neurons and glia. We recently defined that poly(ADP-ribose) (PAR) activity regulates TDP-43-associated toxicity. PAR is a posttranslational modification that is attached to target proteins by PAR polymerases (PARPs). PARP-1 and PARP-2 are the major enzymes that are active in the nucleus. Here, we uncovered that the motor neurons of the ALS spinal cord were associated with elevated nuclear PAR, suggesting elevated PARP activity. Veliparib, a small-molecule inhibitor of nuclear PARP-1/2, mitigated the formation of cytoplasmic TDP-43 aggregates in mammalian cells. In primary spinal-cord cultures from rat, Veliparib also inhibited TDP-43-associated neuronal death. These studies uncover that PAR activity is misregulated in the ALS spinal cord, and a small-molecular inhibitor of PARP-1/2 activity may have therapeutic potential in the treatment of ALS and related disorders associated with abnormal TDP-43 homeostasis.
30157956	8	24	poly(ADP-ribose)	Chemical	MESH:D011064
30157956	61	90	amyotrophic lateral sclerosis	Disease	MESH:D000690
30157956	92	121	Amyotrophic lateral sclerosis	Disease	MESH:D000690
30157956	123	126	ALS	Disease	MESH:D000690
30157956	155	175	motor neuron disease	Disease	MESH:D016472
30157956	278	283	death	Disease	MESH:D003643
30157956	409	416	patient	Species	9606
30157956	448	451	ALS	Disease	MESH:D000690
30157956	492	498	TDP-43	Gene	23435
30157956	512	515	ALS	Disease	MESH:D000690
30157956	516	524	patients	Species	9606
30157956	526	532	TDP-43	Gene	23435
30157956	677	693	poly(ADP-ribose)	Chemical	MESH:D011064
30157956	695	698	PAR	Chemical	MESH:D011064
30157956	719	725	TDP-43	Gene	23435
30157956	737	745	toxicity	Disease	MESH:D064420
30157956	747	750	PAR	Chemical	MESH:D011064
30157956	851	857	PARP-1	Gene	142
30157956	862	868	PARP-2	Gene	10038
30157956	972	975	ALS	Disease	MESH:D000690
30157956	1026	1029	PAR	Chemical	MESH:D011064
30157956	1051	1055	PARP	Gene	142
30157956	1066	1075	Veliparib	Chemical	MESH:C521013
30157956	1115	1123	PARP-1/2	Gene	64761;142;10038
30157956	1164	1170	TDP-43	Gene	23435
30157956	1239	1242	rat	Species	10116
30157956	1244	1253	Veliparib	Chemical	MESH:C521013
30157956	1269	1275	TDP-43	Gene	23435
30157956	1287	1301	neuronal death	Disease	MESH:D009410
30157956	1330	1333	PAR	Chemical	MESH:D011064
30157956	1366	1369	ALS	Disease	MESH:D000690
30157956	1418	1426	PARP-1/2	Gene	64761;142;10038
30157956	1487	1490	ALS	Disease	MESH:D000690
30157956	1538	1544	TDP-43	Gene	23435
30157956	Association	MESH:D000690	10038
30157956	Negative_Correlation	MESH:C521013	MESH:D009410
30157956	Association	10038	23435
30157956	Negative_Correlation	MESH:C521013	64761
30157956	Association	MESH:D000690	142
30157956	Association	MESH:D011064	142
30157956	Association	MESH:D011064	23435
30157956	Association	MESH:D064420	23435
30157956	Negative_Correlation	MESH:C521013	23435
30157956	Association	23435	64761
30157956	Association	MESH:D011064	MESH:D064420
30157956	Association	MESH:D009410	23435
30157956	Negative_Correlation	MESH:C521013	10038
30157956	Association	MESH:D011064	MESH:D000690
30157956	Association	MESH:D000690	23435
30157956	Negative_Correlation	MESH:C521013	142

